Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
NPS discovers and develops small molecule and recombinant protein drugs, primarily for the treatment of metabolic, bone and mineral, and central nervous system disorders. The company has two products on the market, cinacalcet HCl in the US and Europe, and PREOTACT(R) in Europe. The company also has drug candidates in various stages of clinical development backed by a strong discovery research effort. ( www.npsp.com )
NPS Pharmaceuticals , Inc.
383 Colorow Drive
Salt Lake City, Utah 84108
USA
Tel: (801) 583-4939
Fax: (801) 583-4961